- Home
- DDD vs TERN Comparison
DDD vs TERN Comparison
Compare DDD & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDD
- TERN
- Stock Information
- Founded
- DDD 1986
- TERN 2017
- Country
- DDD United States
- TERN United States
- Employees
- DDD N/A
- TERN N/A
- Industry
- DDD Computer peripheral equipment
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- DDD Technology
- TERN Health Care
- Exchange
- DDD Nasdaq
- TERN Nasdaq
- Market Cap
- DDD 411.4M
- TERN 382.2M
- IPO Year
- DDD N/A
- TERN 2021
- Fundamental
- Price
- DDD $3.14
- TERN $4.45
- Analyst Decision
- DDD Buy
- TERN Buy
- Analyst Count
- DDD 3
- TERN 5
- Target Price
- DDD $3.00
- TERN $18.30
- AVG Volume (30 Days)
- DDD 2.2M
- TERN 1.8M
- Earning Date
- DDD 02-25-2025
- TERN 03-13-2025
- Dividend Yield
- DDD N/A
- TERN N/A
- EPS Growth
- DDD N/A
- TERN N/A
- EPS
- DDD N/A
- TERN N/A
- Revenue
- DDD $443,945,000.00
- TERN N/A
- Revenue This Year
- DDD N/A
- TERN N/A
- Revenue Next Year
- DDD $3.28
- TERN N/A
- P/E Ratio
- DDD N/A
- TERN N/A
- Revenue Growth
- DDD N/A
- TERN N/A
- 52 Week Low
- DDD $1.72
- TERN $4.32
- 52 Week High
- DDD $5.75
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- DDD 44.89
- TERN 27.09
- Support Level
- DDD $3.00
- TERN $4.38
- Resistance Level
- DDD $3.66
- TERN $5.95
- Average True Range (ATR)
- DDD 0.19
- TERN 0.29
- MACD
- DDD -0.04
- TERN -0.09
- Stochastic Oscillator
- DDD 20.45
- TERN 4.46
About DDD 3D Systems Corporation
3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, on-demand manufacturing services, and digital design tools. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.